2010, Number 94
<< Back Next >>
Rev Enfer Infec Pediatr 2010; 23.24 (94)
Initial Antiretroviral Theraphy in the child infected with human immunodeficiency virus
Fortuny C, Noguera-Julian A
Language: Spanish
References: 7
Page: 43-45
PDF size: 197.02 Kb.
Text Extraction
No abstract
REFERENCES
Centers for Disease Control. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43 RR 12: 1-10.
Goetghebuer T, Haelterman E, Le Chenadec J, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS 2009; 23: 597-604.
Luzuriaga K, McManus M, Mofenson L, Britto P, Graham B, Sullivan JL. A trial of three antiretroviral regimens in HIV-1-infected children. N Engl J Med 2004; 350: 2471-80.
PENTA Steering Committee, Welch S, Shariand M, et al. PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med 2009; 10: 591-613.
Recomendaciones CEVIHP/SEIP/AEP/PNS respecto al tratamiento antirretroviral en niños y adolescentes infectados por el Virus de la Inmunodeficiencia Humana (VIH). En www.msc.es/ciudadanos/enfLesiones/enfTransmisibles/sida/publicaciones/publicaciones.htm. Consultado el 11 de marzo de 2010.
Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008 Nov 20; 359 (21): 2233-44.
Working Group on Antiretroviral Theraphy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV infection. February 23, 2009; pp 1-139. En http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. Consultado el 11 marzo de 2010.
Full text